ImmunoTek Bio Centers Welcomes New President

SOUTHLAKE, Texas--(BUSINESS WIRE)--ImmunoTek Bio Centers LLC has hired Marvin Dyke as President.

Dyke comes to ImmunoTek with solid experience in the plasma industry, having served six years with Bio-Products Laboratory (BPL) in a variety of executive roles and, most recently, as President of BPL Plasma. In the president role within ImmunoTek, Dyke will be responsible for growing the existing core business of developing plasma centers for customers and expanding the company's industry footprint as a direct supplier to fractionation companies, all while ensuring ImmunoTek maintains its impressive regulatory track record.

Some of Dyke’s notable contributions while at BPL Plasma include the development of 20 new plasma centers; the divestiture of 25 centers to a major fractionator, and the divestiture of BPL Plasma to its current owner in 2022. Before joining BPL Plasma, Marvin was the Managing Partner at MPower Insight, a management consulting firm he founded in 2015. He and his partners helped late-stage startups and family-operated businesses tackle their next stage of growth. Before that, Marvin spent 13 years with Thermo Fisher Scientific in general management, global finance, and operational leadership roles. He served in two expatriate assignments in the U.K. and The Netherlands. During his career with Thermo Fisher, he gained extensive experience with business consolidation and offshoring, clinical packaging, and cold chain logistics. Marvin earned a Bachelor of Science degree in Economics with a minor in Systems Engineering from the United States Military Academy at West Point, and a Master of Business Administration from the University of Virginia’s Darden Graduate School of Business.

Jerome Parnell III, CEO and Board Member of ImmunoTek, stated, “Our organization continues to expand and thrive as we are methodically making an impact within the global plasma industry. We created a thoughtful multi-year strategic plan, which also includes investing in our leadership infrastructure and systems. Most of those refinements are already in progress.” Parnell III continued, “As part of that infrastructure investment, Marvin will have an internal focus and the responsibility of leading and growing our core existing business. We are excited to have him join our leadership team.”

ABOUT IMMUNOTEK BIO CENTERS, LLC

ImmunoTek Bio Centers LLC is the world's largest and fastest-growing independent plasma collection center operator. ImmunoTek is a global leader in developing a reliable plasma supply chain for international biotech companies and partnering with organizations for ancillary projects related to blood-plasma collection. Since its inception in 2013, ImmunoTek has built and operated more than 70 plasma collection centers, most of which have achieved or are in the process of attaining U.S. FDA licensure and European certification. ImmunoTek currently has centers operating in 20 states, with 20 additional centers under development and planning underway for more than 40 additional sites over the next three years. For more information, visit ImmunoTek.com